Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hematopoietic Stem Cell Transplantation
Guidelines for Preventing Opportunistic Infections Among Recipients Issued
November 12th, 2000
The U.S. Centers for Disease Control and Prevention (CDC) announced compilation of "Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant Recipients: Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation." These guidelines were created with the assistance of a working group of experts in infectious diseases, transplantation, and public health. For the purposes of this report, hematopoietic stem cell transplant (HSCT) is defined as any transplantation of blood- or marrow-derived hematopoietic stem cells, regardless of transplant type (i.e., allogeneic or...
Source: Medical Letter on the CDC & FDA (2000-11-12)
|
